ClinVar Miner

Submissions for variant NM_006005.3(WFS1):c.2053C>T (p.Arg685Cys)

gnomAD frequency: 0.00020  dbSNP: rs112967046
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Personalized Diabetes Medicine Program, University of Maryland School of Medicine RCV000445499 SCV000537018 uncertain significance Monogenic diabetes 2016-07-22 criteria provided, single submitter research ACMG Criteria: PP3
Labcorp Genetics (formerly Invitae), Labcorp RCV001351930 SCV001546447 uncertain significance not provided 2025-02-01 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 685 of the WFS1 protein (p.Arg685Cys). This variant is present in population databases (rs112967046, gnomAD 0.06%). This missense change has been observed in individual(s) with clinical features of autosomal recessive WFS1-related conditions (PMID: 34789499). ClinVar contains an entry for this variant (Variation ID: 393391). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt WFS1 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV001351930 SCV001940168 uncertain significance not provided 2023-01-18 criteria provided, single submitter clinical testing Reported with a second variant (phase unknown) in a patient clinically suspected to have monogenic diabetes in published literature (Colclough et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 11920861, 34789499)
3billion, Medical Genetics RCV004668975 SCV002521266 uncertain significance Autosomal dominant nonsyndromic hearing loss 6 2024-07-30 criteria provided, single submitter clinical testing The variant is observed at an allele frequency greater than expected for the associated disorder in the gnomAD v4.0.0 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.80 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.93 (>=0.6, sensitivity 0.72 and precision 0.9)]. Different missense changes at the same codon (p.Arg685His, p.Arg685Pro) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000045446, VCV000215395 / PMID: 18518985). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline.
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV004816668 SCV005073522 uncertain significance Optic atrophy 2021-01-01 criteria provided, single submitter clinical testing
Laboratory of Prof. Karen Avraham, Tel Aviv University RCV002250628 SCV005073827 pathogenic Wolfram syndrome 1 2024-06-13 criteria provided, single submitter research Homozygosity of a very rare variant predicted deleterious by most prediction programs and classified as likely pathogenic by one CLinVar entry.
Fulgent Genetics, Fulgent Genetics RCV005033963 SCV005667528 likely pathogenic Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome 2024-04-11 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004529580 SCV004112224 uncertain significance WFS1-related disorder 2024-04-30 no assertion criteria provided clinical testing The WFS1 c.2053C>T variant is predicted to result in the amino acid substitution p.Arg685Cys. This variant has been reported in the compound heterozygous state along with a truncating variant in a patient with features consistent with Wolfram syndrome (Table S4 and S8, Colclough et al. 2022. PubMed ID: 34789499). This variant was also reported in a study of the relationship between Wolfram syndrome carrier status and suicide (Crawford et al. 2002. PubMed ID: 11920861). A different substitutions at the same codon have been reported in patients with sensorineural hearing loss or early-onset diabetes (p.Arg685Pro, Bramhall et al. 2008. PubMed ID: 18518985; p.Arg685His, Artuso et al. 2015. PubMed ID: 25048417). This variant is reported in 0.056% of alleles in individuals of South Asian descent in gnomAD. While we suspect this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Center for Computational Biology & Bioinformatics, University of California, San Diego RCV004567928 SCV005049976 uncertain significance Meniere disease 2024-06-03 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.